Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy
On Oct. 2, 2024, a study from the GBD Tobacco Forecasting Collaborators reported that by accelerating the decline…
FDA | Life Science News | NIH
FDA Modernization Efforts for Establishing a Unified Human Foods Program launched
On Oct. 1, 2024, the U.S. Food and Drug Administration (FDA) announced that the unified Human Foods Program,…
Biotechnology | Diagnostics | Life Science News | Oncology | Pharmaceutical | Radiology | Therapeutics
Breast Cancer Mortality Continues Three Decade Decline, but Steeper Increases in Incidence for Women <50
On Oct. 1, 2024, the American Cancer Society (ACS) released Breast Cancer Statistics, 2024, the organization’s biennial update…
Mental and health problems concentrated in 20% of the population
On Oct. 1, 2024, a study by the University of Amsterdam and the Trimbos Institute showed that 20%…
Risk of Dementia Diagnosis After Injurious Falls in Older Adults
On Sept. 30, 2024, a research team reported that emerging evidence suggested that mild cognitive impairment, which is…
Medical imaging breakthrough could transform cancer and arthritis diagnosis
On Sept. 30, 2024, a University College London research team announced technology that can deliver photoacoustic tomography (PAT)…
Amneal Launched CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease
On Sept. 30, 2024, Amneal Pharmaceuticals announced that it had launched CREXONT ® (carbidopa and levodopa) extended-release capsules…
Rwanda reports first-ever Marburg virus disease outbreak, with 26 cases confirmed
On Sept. 28, 2024, the World Health Organization (WHO) announced that Rwandan health authorities were intensifying outbreak control…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Neurology | Therapeutics | Vaccine
Brain Scans revealed changes from Long COVID Fatigue
On Sept. 27, 2024, a study that evaluated the structural and functional connectivity correlates of fatigue in post-COVID…
WHO announced Recommendations for influenza vaccine for the 2025 southern hemisphere influenza season
On Sept. 27, 2024, the World Health Organization (WHO) announced the recommendations for the viral composition of influenza…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
New mutation linked to early-onset Parkinsonism
On Sept. 26. 2024, a team of scientists led by Prof. Patrik Verstreken at the VIB-KU Leuven Center…
Stem cells reverse woman’s diabetes — a world first
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
FDA Approved Drug with New Mechanism of Action for Treatment of Schizophrenia
On Sept. 26, 2024, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers Squibb’s Cobenfy (xanomeline and trospium…
Superbugs could jeopardise food security for over two billion people and increase annual health care costs by U.S. $159 billion annually by 2050, finds most extensive modelling to date
On Sept. 25, 2024, drug-resistant pathogens could jeopardise the food supply of over two billion people and increase…
Artificial Intelligence | Biotechnology | Life Science News | Non-Profit Research | Rare Disease | Therapeutics
Researchers used AI to Repurpose Existing Drugs for Treatment of Rare Diseases
On Sept. 25, 2024, a study led by scientists at Harvard Medical School announced they had developed an…
COVID-19 Symptoms Reduced Among U.S. Healthcare Personnel Receiving Additional Vaccine Doses
On Sept. 25, 2024, U.S. healthcare workers receiving additional vaccine doses during the Omicron period (December 2021 to…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | NIH | Therapeutics | U.S. Congress
Mark O. Hatfield Clinical Research Center at the National Institutes of Health dedicated
On Sept. 24, 2024, the Mark O. Hatfield Clinical Research Center at the National Institutes of Health (NIH)…
Biotechnology | COVID-19 | Diagnostics | Life Science News | NIH | Oncology | Therapeutics | Women's Health
New cancer diagnoses did not rebound as expected following pandemic
On Sept. 24, 2024, researchers at the National Institutes of Health (NIH) reported results of a study that…
White House announced 1 million vaccine doses for Africa’s mpox response
On Sept. 24, 2024, U.S. President Joe Biden announced the donation of 1 million mpox vaccine doses and…
Recessive Genes linked to most Developmental Disorders
On Sept. 23, 2024, researchers from the Wellcome Sanger Institute and their collaborators at GeneDx, announced results of…
Study found Pandemic-Era Babies Do Not Have Higher Autism Risk
On Sept. 23, 2024, researchers from Columbia University reported that a study of Children born during the first…
New approach to defibrillation may improve cardiac arrest outcomes
On Sept. 20, 2024, study results released by Oregon Health & Science University (OHSU) researchers suggested placing defibrillation…
Food fussiness a largely genetic trait from toddlerhood to adolescence
On Sept. 20, 2024, a study led by researchers from University College London (UCL), King’s College London and…
FDA Approved Nasal Spray Influenza Vaccine for at home use
On Sept. 20, 2024, the U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is…
Biotechnology | Chemical | Diagnostics | Environmental | Life Science News | Medicine | Non-Profit Research | Therapeutics
New data science tool significantly increased molecular analysis of our environment
On Sept. 20, 2024, a research team led by scientists at the University of California, Riverside, announced they…
Oxitec Launched Sparks™, a Commercial Platform to Scale Dengue-Blocking Wolbachia Solution, Aiming to Protect One Billion People by 2040
On Sept. 19, 2024, Oxitec announced it had launched Sparks™, a new commercial platform to accelerate the global…
Focus on Lyme announced launch of Lyme Disease Test with Over 90% Accuracy
On Sept. 19, 2024, the nonprofit organization Focus on Lyme and Aces Diagnostics announced a breakthrough in Lyme…
EMA recommended extending indication of mpox vaccine to adolescents
On Sept. 19, 2024, the European Medical Agency (EMA) announced it had recommended extending the indication of the…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics | Vaccine
new data showed Over half of U.S. kids infected with RSV in infancy
On Sept. 19, 2024, a U.S. population-based birth cohort study was released that showed that 53.4% of babies…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Vaccine
epicenter of COVID-19 pandemic Genetically traced to market wildlife and viruses
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…